🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Two thirds of U.S. adults don't plan on getting COVID boosters soon - poll

Published 09/30/2022, 01:07 PM
Updated 09/30/2022, 01:11 PM
© Reuters. FILE PHOTO: A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022.  REUTERS/Hannah Beier/File Phot
MRNA
-

By Michael Erman

NEW YORK (Reuters) - Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, according to a survey conducted by the Kaiser Family Foundation (KFF), a health policy nonprofit organization.

Only a third of adults polled said they either already received the updated shots or plan to get the booster as soon as possible, the poll found.

The Pfizer/BioNTech and Moderna (NASDAQ:MRNA) Inc shots, updated to target more recently circulating Omicron subvariants of the coronavirus as well as the original strain, were authorized by the U.S. Food and Drug Administration late last month.

Around 18% said they would wait and see whether they would get the new booster shot, while 10% said they would only get it if it was required. Around 12% of adults surveyed said they would definitely not get the shot, while 27% said they were not eligible because they were not fully vaccinated.

About 7.6 million people received the updated shots over the first four weeks the boosters have been available, according to U.S. Centers for Disease Control and Prevention data released on Thursday. That represents about 3.5% of the 215.5 million people in the United States aged 12 or older who are eligible to receive the shots because they have completed their primary vaccination series.

Awareness of the new vaccines is low, with only half of adults surveyed saying they had heard a lot or some about the boosters, according to the Kaiser survey.

© Reuters. FILE PHOTO: A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022.  REUTERS/Hannah Beier/File Photo

Additionally, around 40% of fully vaccinated adults said they were not sure whether the new COVID-19 boosters are recommended for them. The CDC has recommended the shots for all fully vaccinated people aged 12 and older.

For the survey, KFF polled 1,534 adults from Sept. 15 to Sept. 26.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.